TrademarkDir
AMYLON
LIVE

Serial Number

79230909

Owner

Amylon Therapeutics BV

Attorney

Jess M. Collen

Filing Date

Feb 23, 2018

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

AMYLON Trademark

Serial Number: 79230909 • Registration: 5688231

AMYLON is a trademark filed by Amylon Therapeutics BV on February 23, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 36 (Insurance & Financial), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Amylon Therapeutics BV (2 trademarks)

Zernikedreef 9
NL-2333 CK Leiden , NL

Entity Type: 26

Trademark Details

Filing Date

February 23, 2018

Registration Date

March 5, 2019

Published for Opposition

December 18, 2018

Cancellation Date

September 19, 2025

Goods & Services

Business fundraising for others; financial investment information; financial investment research; capital investment; venture capital funding services for inventors; venture capital funding services to emerging and start-up companies

Pharmaceuticals for treating brain conditions; pharmaceutical compositions for treating brain conditions; pharmaceutical drugs for treating brain conditions; chemico-pharmaceutical preparations for treating brain conditions; sanitary preparations for medical purposes

Laboratory research services relating to pharmaceuticals; medical research; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development in the field of biotechnology; biological research; clinical research in the field of biology and brain conditions; biomedical research services; pharmaceutical research services; research of pharmaceuticals; pharmaceutical products development; testing of pharmaceuticals; pharmaceutical drug development services; research and development of new products for the pharmaceutical industry; consultancy relating to pharmaceutical research and development; consultancy in the field of pharmaceutical research; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Filing History

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
May 19, 2026 INTR
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Dec 2, 2025 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Nov 22, 2025 CRCV
NEW REPRESENTATIVE AT IB RECEIVED
Nov 21, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 21, 2025 NREP
CANCELLED SECTION 71
Sep 19, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 5, 2024 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 19, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 28, 2019 FICS
FINAL DISPOSITION PROCESSED
Jun 28, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 5, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 5, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 18, 2018 NPUB
PUBLISHED FOR OPPOSITION
Dec 18, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Dec 15, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 28, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 28, 2018 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 28, 2018 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 10, 2018 PREV
ASSIGNED TO LIE
Nov 9, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 26, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 26, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 26, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 26, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 26, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 17, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 16, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 16, 2018 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 25, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 25, 2018 REAP
REFUSAL PROCESSED BY IB
Jun 30, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 14, 2018 RFCS
REFUSAL PROCESSED BY MPU
Jun 14, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 9, 2018 RFCR
NON-FINAL ACTION WRITTEN
Jun 8, 2018 CNRT
ASSIGNED TO EXAMINER
Jun 7, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
May 4, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 30, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 26, 2018 REPR

Related Trademarks

More from this Owner

A AMYLON logo

A AMYLON

A AMYLON logo

A AMYLON

A AMYLON logo

A AMYLON